Phase I safety and immunogenicity study of the cytomegal

Project: Research project

Project Details

Description

Phase I safety and immunogenicity study of the cytomegalovirus (CMV) recombinant glycoprotein B vaccine in paired CMV seronegative.....
StatusFinished
Effective start/end date8/9/069/30/07

Funding

  • Sanofi Pasteur

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.